Cavitary Pulmonary Sporotrichosis: Case Report and Literature Review

Mycopathologia. 2017 Dec;182(11-12):1119-1123. doi: 10.1007/s11046-017-0197-6. Epub 2017 Oct 23.

Abstract

A case of cavitary pulmonary sporotrichosis without mucocutaneous involvement caused by Sporothrix schenckii is reported in a sexagenarian woman with a long smoking history. The patient was hospitalized for septic shock with multiorgan failure from a respiratory focus. The diagnosis was delayed due to the fungal etiological agent was not initially considered in the differential diagnosis. A good clinical and radiological evolution was obtained with the antifungal therapy. Occasional cases of primary pulmonary sporotrichosis have been reported in the literature. Due to its low incidence, this is a less-known and underestimated clinical form. Both clinical suspicion and microbiological studies are needed to reach pulmonary sporotrichosis diagnosis.

Keywords: Diagnosis; Pulmonary fungal infection; Sporothrix schenckii; Sporotrichosis.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Aged
  • Amphotericin B / therapeutic use
  • Antifungal Agents / therapeutic use*
  • Female
  • Humans
  • Itraconazole / therapeutic use
  • Lung Diseases, Fungal / diagnosis*
  • Lung Diseases, Fungal / drug therapy*
  • Lung Diseases, Fungal / microbiology
  • Pneumonia / diagnosis
  • Pneumonia / drug therapy
  • Pneumonia / microbiology*
  • Shock, Septic / microbiology
  • Shock, Septic / therapy
  • Smoking / adverse effects
  • Sporothrix / isolation & purification*
  • Sporotrichosis / diagnosis*
  • Sporotrichosis / drug therapy*
  • Sporotrichosis / microbiology

Substances

  • Antifungal Agents
  • liposomal amphotericin B
  • Itraconazole
  • Amphotericin B